In this second part of a three-part video interview series, Brian Anderson, MBA, a principal and consulting actuary at Milliman, shared his belief that PBM transparency is essential—but he sees risks ...

Colorectal cancer screening rates in young adults rise with effective outreach strategies, highlighting the importance of FIT kits for early detection.

In a video interview with MHE editors, Nathan Downhour, Pharm.D., vice president of strategic pharmacy solutions at Prime Therapeutics, said a shift is already underway in the pharmacy benefit market ...

Risks and benefits associated with mail-order pharmacies and third-party platforms, according to Amanda Bogle, a healthcare ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Although a warming planet is bad for human health overall, the prognosis for schizophrenia is particularly poor, researchers argue in a commentary.

Without guardrails, artificial intelligence can be abused, leading to overbilling and high volumes of appeals. But with the ...

In a video interview with MHE editors, David Blair, founder, chairman, and CEO of LucyRx, expressed his belief that pharmacists are an underused resource in the U.S. healthcare system, especially at a ...

Medicare Advantage usage trends reveal slight declines in 2023, highlighting critical insights for policymakers amid rising ...

Pharmacies and PBMs face growing regulatory and reporting demands around drug pricing and reimbursement, while misalignment between state rules and payer practices complicates the expanded clinical ...

Dove’s new line of body care products was developed to address symptoms often associated with menopause, such as skin dryness and body odor.

An expert discusses how vitiligo treatment historically relied on off-label therapies such as topical corticosteroids, calcineurin inhibitors, and phototherapy, but now includes the first FDA-approved ...